Aug. 12, 2004 — The U.S. Food and Drug Administration (FDA) has approved atorvastatin calcium to reduce the risk of heart attack in patients with normal to mildly elevated cholesterol levels and other ...
Princeton, NJ, April 7, 2010 -Sandoz Inc. announced today the introduction in the US of losartan potassium and losartan potassium-hydrochlorothiazide (HCTZ) tablets, authorized generic equivalents of ...
The voice of Michael Corleone--"Just when I thought I was out...they pull me back in"--played over and over again in our heads today when we learned that Apotex filed a Petition for Writ of Certiorari ...
Teva Pharmaceutical Industries has been given the go-ahead in the USA for its generic versions of Merck & Co's blockbuster antihypertensives Cozaar and Hyzaar. Teva Pharmaceutical Industries has been ...
US regulators have given tentative approval to Israeli drugmaker Teva Pharmaceutical Industries’ application for a copycat version of Merck & Co’s Hyzaar, which is used to treat of hypertension and ...
Jerusalem, March 2, 2010- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning ...
Merck & Co., Inc. has announced that the US FDA has approved another new indication for HYZAAR, Merck's fixed-dose combination antihypertensive drug (losartan potassium-hydrochlorothiazide tablets).
PITTSBURGH The Food and Drug Administration has approved two generic drugs by Mylan for treating hypertension, Mylan said Friday. The company announced the approval of losartan potassium and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results